Baillie Gifford - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$14,558
-1.6%
360
+13.2%
0.00%
Q4 2022$14,793
-7.5%
3180.0%0.00%
Q3 2022$16,000
+6.7%
3180.0%0.00%
Q2 2022$15,000
-34.8%
3180.0%0.00%
Q1 2022$23,0003180.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 735,103$8,2113.02%
BRAIDWELL LP 1,038,310$11,597,9230.37%
ARMISTICE CAPITAL, LLC 2,100,000$23,457,0000.36%
FARALLON CAPITAL MANAGEMENT LLC 1,875,000$20,943,7500.10%
PDT Partners, LLC 67,318$751,9420.10%
Virtus ETF Advisers LLC 12,784$142,7970.09%
Portland Global Advisors LLC 34,175$3820.06%
XTX Topco Ltd 27,222$304,0700.05%
Trexquant Investment LP 132,561$1,480,7060.04%
SHERBROOKE PARK ADVISERS LLC 10,100$112,8170.04%
View complete list of ENANTA PHARMACEUTICALS INC shareholders